Distinct effect of retroviral-mediated IFN-α gene transfer on human erythroleukemic and CD34+ cell growth and differentiation

Journal of Hematotherapy and Stem Cell Research

Volumn 8, Issue 5, 1999, Pages 491-502

  Quan, Shuo ^a   Feldman, Eric ^a   Yang, Liming ^a   Wagener, Frank A D T G ^a   Farley, Timothy J ^a   Abraham, Nader G ^a   Ahmed, Tauseef ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CD11B ANTIGEN; CD34 ANTIGEN; CELL ADHESION MOLECULE; FIBRONECTIN; GAMMA INTERFERON; GROWTH FACTOR; VIRUS VECTOR;

ARTICLE; BURST FORMING UNIT E; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CLONOGENIC ASSAY; COLONY FORMING UNIT GM; CONTROLLED STUDY; ERYTHROLEUKEMIA CELL; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RETROVIRUS; VIRUS TITRATION;

ANTIGENS, CD; ANTIGENS, CD34; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL DIVISION; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; INTEGRIN ALPHA4BETA1; INTEGRINS; INTERFERON-ALPHA; K562 CELLS; MACROPHAGE-1 ANTIGEN; POLYMERASE CHAIN REACTION; RECEPTORS, LYMPHOCYTE HOMING; RECEPTORS, VERY LATE ANTIGEN; RETROVIRIDAE; TRANSFECTION;

EID: 0032719804     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581699319948     Document Type: Article

References (40)

1. Jaiyesimi IA, HM Kantarjian and EH Estery. (1993). Advances in therapy for hair cell leukemia. A review. Cancer 72:5.
2. Murray JL, DL Macery, EJ Grant, et al. (1995). Enhancer TAG-72 expression and tumor uptake of radiolabeled monoclonal antibody CC49 in metastatic breast cancer patients following alpha-interferon treatment. Cancer Res 55: 5925S.
3. Molto L, MM Alvarez, J Carballidd, et al. (1994). Intracavitary prophylactic treatment with interferon alpha 2b of patients with superficial bladder cancer is associated with a systemic T-cell activation. Br J Cancer 70:1247.
4. Maxwell W, J Mcdevitt, I Reid, et al. (1993). Changes in immunological parameters during interleukin 2 and interferon 2 alpha treatment of recurrent renal cell carcinoma and malignant melanoma. Eur J Surg Oncol 19:265.
5. Reiter A, H Skladny, A Hochhaus, et al. (1997). Molecular response of CML patients treated with interferon-alpha monitored by quantitative Southern blot analysis. German chronic myeloid leukemia (CML) study group. Br J Haematol 97:86.
6. Goldman JM, and DP Lu. (1982). New approaches in chromic granulocytic leukemia: origin, prognosis, and treatment. Semin Hematol 19:241.
7. Cortes JE, M Talpaz and H Kantarjian. (1996). Chronic myelogenous leukemia: a review. Am J Med 100:555.
8. Butturini A, A Keating, J Goldman, et al. (1990). Autotransplants in chronic myelogenous leukaemia: strategies and results. Lancet 335:1255.
9. Jones RJ. (1997). Biology of treatment of chronic myeloid leukemia. Curr Opin Oncol 9:3.
10. Talpaz M, HM Kantarjian, R Kurzrock, et al. (1991). Inteiferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Ann Intern Med 114:532.
11. Chertkov JL, S Jiang, JD Lutton, et al. (1993). The hematopoietic stromal microenvironment promotes retrovirus-mediated gene transfer into hematopoietic stem cells. Stem Cells 11:218.
12. Abraham NG, JL Da Silva, Y Lavrovsky, et al. (1995). Adenovirus-mediated heme oxygenase-1 gene transfer into rabbit ocular tissues. Invest Ophthalmol Vis Sci 36:2202.
13. Ahmed T, JD Lutton, E Feldman, et al. (1998). Gene transfer of alpha interferon into hematopoietic stem cells. Leuk Res 22:119.
14. + cells and CML mononuclear cells. Stem Cells 15:386.
15. Ogura H, K Tani, K Ozawa, et al. (1990). Implantation of genetically manipulated fibroblasts into mice as antitumor α-interferon therapy. Cancer Res 50:5102.
16. Markowitz D, S Goff, and A Bank. (1988). Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167:400.
17. Zhang JF, C Hu, Y Geng, et al. (1996). Treatment of a human breast cancer xenograft with an adenovirus vector containing an interferon gene results in rapid regression due to viral oncolysis and gene therapy. Proc Natl Acad Sci USA 93:4513.
18. Geng Y, D Yu, LM Blatt, et al. (1995). Tumor suppressor activity of the human consensus type I interferon gene. Cytokines Mol Ther 1:289.
19. Rubinstein S, PC Familletti and S Pestka. (1981). Convenient assay for interferons. J Virol 37:755.
20. Koshiji M, Y Adachi, S Taketani, et al. (1997). Mechanisms underlying apoptosis induced by combination of 5fluorouracil and interferon-γ. Biochem Biophys Res Commun 240:376.
21. Verfaillie CM, WJ Miller, K Boylan, et al. (1992). Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Blood 79:1003.
22. Nicoletti I, G Migliorati, MC Pagliacci, et al. (1991). A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271.
23. Wong GH, LA Tartaglia, MS Lee, et al. (1992). Antiviral activity of tumor necrosis factor is signaled through the 55-kDa receptor, type I TNF receptor. J Immunol 149:3350.
24. Samuel CE. (1991). Antiviral actions of interferon: interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 183:1.
25. Baca-Regen L, N Heinzinger, M Stevenson, et al. (1994). Alpha interferon-induced antiretroviral activities: restriction of viral nucleic acid synthesis and progeny virion production in human immunodeficiency virus type 1-infected monocytes. J Virol 68:7559.
26. Hottiger MO, LK Felzien, and GJ Nabel. (1998). Modulation of cytokine-induced HIV gene expression by competitive binding of transcription factors to the coactivator p300. EMBO J 17:3124.
27. Miller AD, and GJ Rosman. (1989). Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980.
28. Miller AD, DG Miller, JV Garcia, et al. (1993). Use of retroviral vectors for gene transfer and expression. Methods Enzymol 217:581.
29. Harms JS, and GA Splitter. (1995). Interferon-γ inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter. Hum Gene Ther 6:1291.
30. Qin L, Y Ding, DR Pahud, et al. (1997). Promoter attenuation in gene therapy: interferon-γ and tumor necrosis factor-α inhibit transgene expression. Hum Gene Ther 8:2019.
31. Stein J, HD Volk, C Liebenthal, et al. (1993). Tumor necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate-early enhancer/promoter in immature monocytic cells. J Gen Virol 74:2333.
32. Austruy E, C Bagnis, P Dubreuil, et al. (1996). Retroviral gene transfer of the human interferon alpha-2 gene in human hematopoietic cell lines. Blood 88:434a.
33. BCR/ABL gene of the Philadelphia chromosome. Science 247:824.
34. Gishizky ML, and ON Witter. (1992). Initiation of deregulated growth of multipotent progenitor cells by bcr-abl in vitro. Science 256:836.
35. Zhao RC, RS McIvor, JD Griffin, et al. (1997). Gene therapy for chronic myelogenous leukemia (CML): a retroviral vector that renders hematopoietic progenitors methotrexate-resistant and CML progenitors functionally normal and nontumorigenic in vivo. Blood 90:4687.
36. Austruy E, C Bagnis, N Carbuccia, et al. (1998). A defective retroviral vector encoding human interferon-α2 can transduce human leukemic cell lines. Cancer Gene Ther 5:247.
37. 1-pintegrin receptor function. J Clin Invest 94:384.
38. Gordon MY, CR Dowding, GP Riley, et al. (1987). Altered adhesive interactions with marrow stromas of haematopoietic progenitors cells in chronic myeloid leukaemia. Nature 328:342.
39. Yang LM, E Feldman, S Quan, et al. (1998). Retroviralmediated gene transfer of human interferon alpha efficiently inhibits K562 cell growth and modulates adhesion molecule expression. Blood 92:255a (abstract).
40. Moritz T, P Dutt, X Xiao, et al. (1996). Fibronectin improves transduction of reconstituting stem cells by retroviral vectors: evidence of direct viral binding to chymotryptic carboxy-terminal fragments. Blood 88: 855.